Aug. 24, 2017—North West London Pathology, hosted by Imperial College Healthcare NHS Trust, and Abbott have signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott’s Alinity ci and Alinity h series diagnostics instruments as well as its professional services and informatics solutions known as AlinIQ.
The contract was the subject of a detailed and competitive procurement process conducted by NWLP. Imperial College Healthcare NHS Trust, Chelsea and Westminster NHS Foundation Trust, and the Hillingdon Hospitals NHS Foundation Trust consolidated their pathology services into NWLP earlier this year.
“NWLP aims to provide an innovative and sustainable pathology service which delivers outstanding quality for our patients and clinicians. After a highly competitive process involving multiple diagnostic equipment manufacturers, NWLP is extremely excited to be working with Abbott, which supports our vision of increased efficiency and transformation across six major sites in North West London using the latest technology,” Stephen Snewin, managing director of NWLP, said in a statement.
The partnership is expected to manage 26 million tests per year and currently holds six percent of the total pathology market in the United Kingdom, according to NWLP.